Tag: BVEC
New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American...
PITTSBURGH, March 26, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., ("Krystal Biotech") KRYS, the leader in redosable gene therapies for rare diseases,...